Public Health, Consumer Advocates Lukewarm On Gottlieb, Question Approval Decisions

Despite glowing praise from industry, public health and consumer advocates are lukewarm over the action FDA has taken during Scott Gottlieb's first 100 days as FDA commissioner -- holding up several recent product decisions they view as troublesome. One public health advocate said Gottlieb's move not to reverse what some view as a several-year decline in FDA approval standards could be contributing to rising medical costs -- despite the commissioner's activist role in pushing competition to control drug costs. But...